Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above January 12, 2023January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Roche announces U.S. FDA approval of Xofluza to…European Commission approves Roche’s Gavreto…European Commission approves Roche’s Tecentriq as…Roche’s Polivy combination approved by European…European Commission approves Roche’s first-in-class…European Commission approves Roche’s Vabysmo, the…
